Role of Pyroptosis in Acetaminophen-Induced Hepatotoxicity.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 425, doi. 10.3390/livers2040032
- By:
- Publication type:
- Article
Works matching IS 26734389 AND DT 2022 AND VI 2 AND IP 4
Results: 13
1
2
A Simple Algorithm for Semiquantitative Analysis of Scored Histology Data in the R Environment, on the Example of Murine Non-Alcoholic Steatohepatitis Pharmacotherapy.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 412, doi. 10.3390/livers2040031
- By:
- Publication type:
- Article
3
Anti-Metastatic Activity of Tagitinin C from Tithonia diversifolia in a Xenograft Mouse Model of Hepatocellular Carcinoma.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 400, doi. 10.3390/livers2040030
- By:
- Publication type:
- Article
4
Preclinical Experience of the Mayo Spheroid Reservoir Bioartificial Liver (SRBAL) in Management of Acute Liver Failure.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 387, doi. 10.3390/livers2040029
- By:
- Publication type:
- Article
5
Liver Fibrosis, Liver Cancer, and Advances in Therapeutic Approaches.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 372, doi. 10.3390/livers2040028
- By:
- Publication type:
- Article
6
FYB2 Is a Potential Prognostic Biomarker for Hepatocellular Carcinoma.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 361, doi. 10.3390/livers2040027
- By:
- Publication type:
- Article
7
Synergistic Anti-Tumor Effect of Palmitoylcarnitine and Dasatinib in Liver Cancer.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 344, doi. 10.3390/livers2040026
- By:
- Publication type:
- Article
8
Breath Analysis in Children with Ketogenic Glycogen Storage Diseases.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 336, doi. 10.3390/livers2040025
- By:
- Publication type:
- Article
9
Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?
- Published in:
- Livers, 2022, v. 2, n. 4, p. 315, doi. 10.3390/livers2040024
- By:
- Publication type:
- Article
10
Role of Oxidative Stress in Liver Disorders.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 283, doi. 10.3390/livers2040023
- By:
- Publication type:
- Article
11
Risk Prevention and Health Promotion for Non-Alcoholic Fatty Liver Diseases (NAFLD).
- Published in:
- Livers, 2022, v. 2, n. 4, p. 264, doi. 10.3390/livers2040022
- By:
- Publication type:
- Article
12
Alagille Syndrome and Its Clinical and Laboratory Features: A Case Report.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 258, doi. 10.3390/livers2040021
- By:
- Publication type:
- Article
13
One Carbon Metabolism and S -Adenosylmethionine in Non-Alcoholic Fatty Liver Disease Pathogenesis and Subtypes.
- Published in:
- Livers, 2022, v. 2, n. 4, p. 243, doi. 10.3390/livers2040020
- By:
- Publication type:
- Article